Global Anti-Glaucoma Ophthalmic Drug Market Research Report 2016

November 2016 | 104 pages | ID: GA76EDED91CEN
QYResearch

Abstracts

Notes:

Production, means the output of Anti-Glaucoma Ophthalmic Drug

Revenue, means the sales value of Anti-Glaucoma Ophthalmic Drug

This report studies Anti-Glaucoma Ophthalmic Drug in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering

• Bayer HealthCare Pharmaceuticals (Germany)
• Pfizer Incorporated (USA)
• GlaxoSmithKline Plc (UK)
• Merck & Company Incorporated (USA)
• Syneron Medical Ltd. (Israel)
• Valeant Pharmaceuticals International (USA)

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Anti-Glaucoma Ophthalmic Drug in these regions, from 2011 to 2021 (forecast), like

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by application, this report focuses on consumption, market share and growth rate of Anti-Glaucoma Ophthalmic Drug in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Anti-Glaucoma Ophthalmic Drug Market Research Report 2016

1 ANTI-GLAUCOMA OPHTHALMIC DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Anti-Glaucoma Ophthalmic Drug
1.2 Anti-Glaucoma Ophthalmic Drug Segment by Type
  1.2.1 Global Production Market Share of Anti-Glaucoma Ophthalmic Drug by Type in 2015
  1.2.2 Type I
  1.2.3 Type II
  1.2.4 Type III
1.3 Anti-Glaucoma Ophthalmic Drug Segment by Application
  1.3.1 Anti-Glaucoma Ophthalmic Drug Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Anti-Glaucoma Ophthalmic Drug Market by Region
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 Europe Status and Prospect (2011-2021)
  1.4.3 China Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Anti-Glaucoma Ophthalmic Drug (2011-2021)

2 GLOBAL ANTI-GLAUCOMA OPHTHALMIC DRUG MARKET COMPETITION BY MANUFACTURERS

2.1 Global Anti-Glaucoma Ophthalmic Drug Production and Share by Manufacturers (2015 and 2016)
2.2 Global Anti-Glaucoma Ophthalmic Drug Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Anti-Glaucoma Ophthalmic Drug Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Anti-Glaucoma Ophthalmic Drug Manufacturing Base Distribution, Sales Area and Product Type
2.5 Anti-Glaucoma Ophthalmic Drug Market Competitive Situation and Trends
  2.5.1 Anti-Glaucoma Ophthalmic Drug Market Concentration Rate
  2.5.2 Anti-Glaucoma Ophthalmic Drug Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL ANTI-GLAUCOMA OPHTHALMIC DRUG PRODUCTION, REVENUE (VALUE) BY REGION (2011-2016)

3.1 Global Anti-Glaucoma Ophthalmic Drug Production and Market Share by Region (2011-2016)
3.2 Global Anti-Glaucoma Ophthalmic Drug Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Anti-Glaucoma Ophthalmic Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Anti-Glaucoma Ophthalmic Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Anti-Glaucoma Ophthalmic Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Anti-Glaucoma Ophthalmic Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Anti-Glaucoma Ophthalmic Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Anti-Glaucoma Ophthalmic Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India Anti-Glaucoma Ophthalmic Drug Production, Revenue, Price and Gross Margin (2011-2016)

4 GLOBAL ANTI-GLAUCOMA OPHTHALMIC DRUG SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2011-2016)

4.1 Global Anti-Glaucoma Ophthalmic Drug Consumption by Regions (2011-2016)
4.2 North America Anti-Glaucoma Ophthalmic Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Anti-Glaucoma Ophthalmic Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Anti-Glaucoma Ophthalmic Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Anti-Glaucoma Ophthalmic Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Anti-Glaucoma Ophthalmic Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Anti-Glaucoma Ophthalmic Drug Production, Consumption, Export, Import by Regions (2011-2016)

5 GLOBAL ANTI-GLAUCOMA OPHTHALMIC DRUG PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Anti-Glaucoma Ophthalmic Drug Production and Market Share by Type (2011-2016)
5.2 Global Anti-Glaucoma Ophthalmic Drug Revenue and Market Share by Type (2011-2016)
5.3 Global Anti-Glaucoma Ophthalmic Drug Price by Type (2011-2016)
5.4 Global Anti-Glaucoma Ophthalmic Drug Production Growth by Type (2011-2016)

6 GLOBAL ANTI-GLAUCOMA OPHTHALMIC DRUG MARKET ANALYSIS BY APPLICATION

6.1 Global Anti-Glaucoma Ophthalmic Drug Consumption and Market Share by Application (2011-2016)
6.2 Global Anti-Glaucoma Ophthalmic Drug Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL ANTI-GLAUCOMA OPHTHALMIC DRUG MANUFACTURERS PROFILES/ANALYSIS

7.1 Bayer HealthCare Pharmaceuticals (Germany)
  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.1.2 Anti-Glaucoma Ophthalmic Drug Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Bayer HealthCare Pharmaceuticals (Germany) Anti-Glaucoma Ophthalmic Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.1.4 Main Business/Business Overview
7.2 Pfizer Incorporated (USA)
  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.2.2 Anti-Glaucoma Ophthalmic Drug Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Pfizer Incorporated (USA) Anti-Glaucoma Ophthalmic Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.2.4 Main Business/Business Overview
7.3 GlaxoSmithKline Plc (UK)
  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.3.2 Anti-Glaucoma Ophthalmic Drug Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 GlaxoSmithKline Plc (UK) Anti-Glaucoma Ophthalmic Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.3.4 Main Business/Business Overview
7.4 Merck & Company Incorporated (USA)
  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.4.2 Anti-Glaucoma Ophthalmic Drug Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Merck & Company Incorporated (USA) Anti-Glaucoma Ophthalmic Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.4.4 Main Business/Business Overview
7.5 Syneron Medical Ltd. (Israel)
  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.5.2 Anti-Glaucoma Ophthalmic Drug Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Syneron Medical Ltd. (Israel) Anti-Glaucoma Ophthalmic Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.5.4 Main Business/Business Overview
7.6 Valeant Pharmaceuticals International (USA)
  7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.6.2 Anti-Glaucoma Ophthalmic Drug Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Valeant Pharmaceuticals International (USA) Anti-Glaucoma Ophthalmic Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.6.4 Main Business/Business Overview

8 ANTI-GLAUCOMA OPHTHALMIC DRUG MANUFACTURING COST ANALYSIS

8.1 Anti-Glaucoma Ophthalmic Drug Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Anti-Glaucoma Ophthalmic Drug

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Anti-Glaucoma Ophthalmic Drug Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Anti-Glaucoma Ophthalmic Drug Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL ANTI-GLAUCOMA OPHTHALMIC DRUG MARKET FORECAST (2016-2021)

12.1 Global Anti-Glaucoma Ophthalmic Drug Production, Revenue Forecast (2016-2021)
12.2 Global Anti-Glaucoma Ophthalmic Drug Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Anti-Glaucoma Ophthalmic Drug Production Forecast by Type (2016-2021)
12.4 Global Anti-Glaucoma Ophthalmic Drug Consumption Forecast by Application (2016-2021)
12.5 Anti-Glaucoma Ophthalmic Drug Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Anti-Glaucoma Ophthalmic Drug
Figure Global Production Market Share of Anti-Glaucoma Ophthalmic Drug by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Anti-Glaucoma Ophthalmic Drug Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Anti-Glaucoma Ophthalmic Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Anti-Glaucoma Ophthalmic Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Anti-Glaucoma Ophthalmic Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Anti-Glaucoma Ophthalmic Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Anti-Glaucoma Ophthalmic Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Anti-Glaucoma Ophthalmic Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Anti-Glaucoma Ophthalmic Drug Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Anti-Glaucoma Ophthalmic Drug Production of Key Manufacturers (2015 and 2016)
Table Global Anti-Glaucoma Ophthalmic Drug Production Share by Manufacturers (2015 and 2016)
Figure 2015 Anti-Glaucoma Ophthalmic Drug Production Share by Manufacturers
Figure 2016 Anti-Glaucoma Ophthalmic Drug Production Share by Manufacturers
Table Global Anti-Glaucoma Ophthalmic Drug Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Anti-Glaucoma Ophthalmic Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Anti-Glaucoma Ophthalmic Drug Revenue Share by Manufacturers
Table 2016 Global Anti-Glaucoma Ophthalmic Drug Revenue Share by Manufacturers
Table Global Market Anti-Glaucoma Ophthalmic Drug Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Anti-Glaucoma Ophthalmic Drug Average Price of Key Manufacturers in 2015
Table Manufacturers Anti-Glaucoma Ophthalmic Drug Manufacturing Base Distribution and Sales Area
Table Manufacturers Anti-Glaucoma Ophthalmic Drug Product Type
Figure Anti-Glaucoma Ophthalmic Drug Market Share of Top 3 Manufacturers
Figure Anti-Glaucoma Ophthalmic Drug Market Share of Top 5 Manufacturers
Table Global Anti-Glaucoma Ophthalmic Drug Production by Regions (2011-2016)
Figure Global Anti-Glaucoma Ophthalmic Drug Production and Market Share by Regions (2011-2016)
Figure Global Anti-Glaucoma Ophthalmic Drug Production Market Share by Regions (2011-2016)
Figure 2015 Global Anti-Glaucoma Ophthalmic Drug Production Market Share by Regions
Table Global Anti-Glaucoma Ophthalmic Drug Revenue by Regions (2011-2016)
Table Global Anti-Glaucoma Ophthalmic Drug Revenue Market Share by Regions (2011-2016)
Table 2015 Global Anti-Glaucoma Ophthalmic Drug Revenue Market Share by Regions
Table Global Anti-Glaucoma Ophthalmic Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Anti-Glaucoma Ophthalmic Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Anti-Glaucoma Ophthalmic Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table China Anti-Glaucoma Ophthalmic Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Anti-Glaucoma Ophthalmic Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Anti-Glaucoma Ophthalmic Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table India Anti-Glaucoma Ophthalmic Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Anti-Glaucoma Ophthalmic Drug Consumption Market by Regions (2011-2016)
Table Global Anti-Glaucoma Ophthalmic Drug Consumption Market Share by Regions (2011-2016)
Figure Global Anti-Glaucoma Ophthalmic Drug Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Anti-Glaucoma Ophthalmic Drug Consumption Market Share by Regions
Table North America Anti-Glaucoma Ophthalmic Drug Production, Consumption, Import & Export (2011-2016)
Table Europe Anti-Glaucoma Ophthalmic Drug Production, Consumption, Import & Export (2011-2016)
Table China Anti-Glaucoma Ophthalmic Drug Production, Consumption, Import & Export (2011-2016)
Table Japan Anti-Glaucoma Ophthalmic Drug Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Anti-Glaucoma Ophthalmic Drug Production, Consumption, Import & Export (2011-2016)
Table India Anti-Glaucoma Ophthalmic Drug Production, Consumption, Import & Export (2011-2016)
Table Global Anti-Glaucoma Ophthalmic Drug Production by Type (2011-2016)
Table Global Anti-Glaucoma Ophthalmic Drug Production Share by Type (2011-2016)
Figure Production Market Share of Anti-Glaucoma Ophthalmic Drug by Type (2011-2016)
Figure 2015 Production Market Share of Anti-Glaucoma Ophthalmic Drug by Type
Table Global Anti-Glaucoma Ophthalmic Drug Revenue by Type (2011-2016)
Table Global Anti-Glaucoma Ophthalmic Drug Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Anti-Glaucoma Ophthalmic Drug by Type (2011-2016)
Figure 2015 Revenue Market Share of Anti-Glaucoma Ophthalmic Drug by Type
Table Global Anti-Glaucoma Ophthalmic Drug Price by Type (2011-2016)
Figure Global Anti-Glaucoma Ophthalmic Drug Production Growth by Type (2011-2016)
Table Global Anti-Glaucoma Ophthalmic Drug Consumption by Application (2011-2016)
Table Global Anti-Glaucoma Ophthalmic Drug Consumption Market Share by Application (2011-2016)
Figure Global Anti-Glaucoma Ophthalmic Drug Consumption Market Share by Application in 2015
Table Global Anti-Glaucoma Ophthalmic Drug Consumption Growth Rate by Application (2011-2016)
Figure Global Anti-Glaucoma Ophthalmic Drug Consumption Growth Rate by Application (2011-2016)
Table Bayer HealthCare Pharmaceuticals (Germany) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer HealthCare Pharmaceuticals (Germany) Anti-Glaucoma Ophthalmic Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer HealthCare Pharmaceuticals (Germany) Anti-Glaucoma Ophthalmic Drug Market Share (2011-2016)
Table Pfizer Incorporated (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Incorporated (USA) Anti-Glaucoma Ophthalmic Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Incorporated (USA) Anti-Glaucoma Ophthalmic Drug Market Share (2011-2016)
Table GlaxoSmithKline Plc (UK) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Plc (UK) Anti-Glaucoma Ophthalmic Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline Plc (UK) Anti-Glaucoma Ophthalmic Drug Market Share (2011-2016)
Table Merck & Company Incorporated (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck & Company Incorporated (USA) Anti-Glaucoma Ophthalmic Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Merck & Company Incorporated (USA) Anti-Glaucoma Ophthalmic Drug Market Share (2011-2016)
Table Syneron Medical Ltd. (Israel) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Syneron Medical Ltd. (Israel) Anti-Glaucoma Ophthalmic Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Syneron Medical Ltd. (Israel) Anti-Glaucoma Ophthalmic Drug Market Share (2011-2016)
Table Valeant Pharmaceuticals International (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Valeant Pharmaceuticals International (USA) Anti-Glaucoma Ophthalmic Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Valeant Pharmaceuticals International (USA) Anti-Glaucoma Ophthalmic Drug Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anti-Glaucoma Ophthalmic Drug
Figure Manufacturing Process Analysis of Anti-Glaucoma Ophthalmic Drug
Figure Anti-Glaucoma Ophthalmic Drug Industrial Chain Analysis
Table Raw Materials Sources of Anti-Glaucoma Ophthalmic Drug Major Manufacturers in 2015
Table Major Buyers of Anti-Glaucoma Ophthalmic Drug
Table Distributors/Traders List
Figure Global Anti-Glaucoma Ophthalmic Drug Production and Growth Rate Forecast (2016-2021)
Figure Global Anti-Glaucoma Ophthalmic Drug Revenue and Growth Rate Forecast (2016-2021)
Table Global Anti-Glaucoma Ophthalmic Drug Production Forecast by Regions (2016-2021)
Table Global Anti-Glaucoma Ophthalmic Drug Consumption Forecast by Regions (2016-2021)
Table Global Anti-Glaucoma Ophthalmic Drug Production Forecast by Type (2016-2021)
Table Global Anti-Glaucoma Ophthalmic Drug Consumption Forecast by Application (2016-2021)